Latest News Archive

Please select Category, Year, and then Month to display items

The first clinical PhD in nuclear medicine completed at the UFS

18 April 2024 | Story Andre Damons | Photo Charl Devenish

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans.

News Archive

Government to benefit from training of interpreters

2009-03-31

Pictured, from the left, are: Prof Theo du Plessis (Director: Unit for Language Management, UFS), Ms Mokone Nthongoa (HOD: Sport, FS Department of Sport, Arts and Culture), Mr Khotso Sesele (MEC: FS Department of Sport, Arts and Culture) and Prof Engela Pretorius (Vice Dean: Faculty of the Humanities, UFS).
Photo: Mangaliso Radebe

Government to benefit from training of interpreters

The fourth phase of a project to train eight conference interpreters and 30 community interpreters to assist government departments at service delivery points in the Free State was launched this week.

The project is part of the Multilingualism Information Development Programme which brings together the Free State provincial government, the Province of Antwerp and the University of Antwerp in Belgium and the University of the Free State (UFS).

Speaking at the launch of the fourth phase of the project, the MEC for Sport, Arts and Culture in the Free State, Mr Khotso Sesele, said: “The fact that we have been through the first three stages of this project, and are now launching its fourth phase, is indicative of the magnificent progress that has been made. This is a sign that through partnerships we can achieve more.”

The MIDP IV consists of two pillars, namely a practical and a research component. Its aim is to generate interpreting capacity within the provincial Department of Sport, Arts and Culture. The focus is on training an interpreting team over three years which can be employed within a governmental context at various service points.

“As we approach the 2009 FIFA Confederation Cup and the 2010 FIFA World Cup tournaments, it will be important for our communities to be able to interact with millions of foreign nationals who will be in our country from different world destinations during and beyond these two important soccer events,” said the MEC.

“The focus on interpreter training by this fourth phase of MIDP is thus an important factor in ensuring better communication during and beyond these important soccer spectacles that will take place in our country.”
The focus of the first three phases of the MIDP was on the main official languages of the province. This fourth phase, which started in 2008, will run until 2010 and its focus is on the Xhariep District Municipality.

“The provision of interpreting services and its further extension to district municipalities will provide the necessary interpreting skills to our communities that will enhance better interaction amongst ourselves,” said Mr Sesele.

He said the fact that indigenous languages have been “elevated from their marginalised status to being languages of business and commerce” is an important milestone that must be cherished.

This fourth phase of MIDP will also incorporate sign language as part of its focus on interpreting services.

“In our quest to ensure a multilingual dispensation in our province, we need not neglect to remember people with disabilities,” he said. “This is a matter of principle that does not require debate.”

“We should thus ensure the realisation of the goal of MIDP IV which is to ensure smooth communication interaction within the wider public, including the deaf community.”

“This is a wonderful project,” said Ms Mathabo Monaheng, one of the students in the MIDP. “As a sign language interpreter trainee this project will empower me with the necessary skills to be able to make a meaningful contribution to the deaf community in terms of communication.”

The MIDP is funded by the Province of Antwerp and successfully implemented by the Unit for Language Management at the UFS.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za
31 March 2009

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept